|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Ventilator associated pneumonia (VAP) is a common hospital acquired infection. Its prevalence ranges from 9-24%. It leads to increased mortality and increased health care costs. VAP due to Acinetobacter baumannii is notorious for its multidrug resistance potential. The study reveals the characteristics of Acinetobacter baumanii in a tertiary care hospital. This is a prospective study of 100 patients. The endotracheal aspirates were collected, processed and isolate identified. Antimicrbial susceptibility testing was done, biofilm testing and MIC testing for Meropenem was also done. The incidence of Acinetobacter VAP was 31%. Multisystem disorders and neurological disorders were associated with Acinetobacter VAP. 83.87% isolates were multidrug resistant. 54.84% of isolates were strong biofilm producers. 61.29% of isolates were resistant to Meropenem by MIC testing by microbroth dilution method. Proper infection control measures, judicious use of antibiotics with implementation of ventilator care bundle will retard the development of VAP in ICU.